Product Description
Overall, the global intra aortic balloon device market was valued at $226.7million in 2025. This is expected to increase over the forecast period at a CAGR of 3.9% to reach $295.9 million.
The full report suite on the global market for intra-aortic balloon (IAB) device includes disposable devices and intra-aortic balloon pump (IABP) consoles. The disposable IAB device segment includes conventional and fiber-optic IAB catheters.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Intra Aortic Balloon Device Market Trends
The global intra-aortic balloon (IAB) device market is experiencing gradual transition as clinical practice continues to evolve. While IABP systems remain in use for selected cardiac surgery and critical care cases, their role is increasingly constrained by the availability of higher-support mechanical circulatory support devices. In parallel, recent recalls and regulatory actions affecting both IABP consoles and disposable balloon catheters have heightened hospital focus on safety and replacement planning, reinforcing a cautious purchasing environment centered on maintaining installed systems rather than market expansion.
Intra Aortic Balloon Device Market Share Insights
- Getinge was the leading competitor in the global IABP market in 2025, offering a broad portfolio of consoles, including the CARDIOSAVE® IABP Hybrid, CARDIOSAVE® IABP Rescue, and the CS300™ IABP with Intellisense™ technology, alongside disposable IAB catheters such as the SENSATION® 7Fr fiber-optic balloon. Getinge’s strong position reflects the long-term impact of its acquisition of Datascope, a former market leader in IABP technology. In 2024, the U.S. FDA issued an advisory recommending that healthcare providers phase out certain Cardiosave systems due to safety and quality concerns. Despite this, Getinge reaffirmed its commitment to the IABP segment, announcing plans to focus resources on its IABP and extracorporeal membrane oxygenation (ECMO) product lines.
- Teleflex ranked as the second-leading competitor in the global intra-aortic balloon pump (IABP) market in 2025, supported by a portfolio of capital equipment that includes the AutoCAT®2, AutoCAT®2 WAVE, and the transport-oriented AC3 Range™ IABP system. The AC3 Range™ received U.S. FDA 510(k) clearance in April 2025 and entered commercial distribution later that year. Teleflex also offers a range of disposable intra-aortic balloon catheters designed for use with its IABP consoles. In 2024, the company was subject to an FDA Class I recall involving certain Arrow® FiberOptix™ and UltraFlex™ intra-aortic balloon catheter kits due to a manufacturing issue that could affect balloon inflation, leading to corrective actions and updated usage guidance. Overall, Teleflex has maintained a significant presence in the global IABP market while continuing to develop and commercialize new system offerings.
Intra Aortic Balloon Device Market Segmentation Summary
- Intra-Aortic Balloon Device Market – Further Segmented Into:
- Device Type: IAB Catheters and IABP Consoles.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
